Regeneus is proud to announce that Associate Professor Ben Herbert will be giving a lecture at the upcoming Science Research Lecture Series at Macquarie University.
Regenerative medicine company, Regeneus, has completed the treatment phase for the Phase II clinical trial of the company’s HiQCell therapy for knee osteoarthritis.
Regeneus today announced positive early trial results for CryoShot, its new "off-the-shelf" stem cell therapy for the treatment of inflammatory musculoskeletal disorders in horses and dogs.
